Medindia

X

CardioTech Announces Conference Call on November 13 at 2:30 PM Eastern For Second Quarter of Fiscal 2008

Tuesday, November 6, 2007 General News J E 4
Advertisement
WILMINGTON, Mass., Nov. 5 CardioTechInternational, Inc. (Amex: CTE), a developer and manufacturer of advancedmaterials and medical devices for the treatment of cardiovascular and otherdiseases, announced today that it will release its fiscal 2008 second quarterfinancial results before the market opens on Tuesday, November 13, 2007.Following the release, the Company will host a conference call for investorsat 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal second quarter results.

Participants should dial-in (866) 835-8845 Conference ID# 1155065 or(703) 639-1408 outside the U.S. Please dial-in 10 minutes before the call isscheduled to begin. A replay of the call will be available for two weeksfollowing the call at (888)-266-2081 ID# 155065 and on the Company's website.

About CardioTech International:

CardioTech is a developer of advanced polymer materials and manufacturerof medical products for the treatment and diagnosis of a broad range ofdisease states. The Company's business model leverages its proprietarymaterials science technology and manufacturing expertise in order to expandits product sales and royalty and license fee income. It develops nextgeneration polymers and manufactures new and complex medical devices tocustomers' unique specifications. CardioTech is conducting its first clinicaltrial for regulatory approval in Europe for its CardioPass synthetic coronarybypass graft. More information about CardioTech is available at its website:http://www.cardiotech-inc.com.For Further Information Contact: Eric Walters Sylvia Dresner Vice President & Chief Financial Officer Senior Vice President CardioTech International, Inc. VMW Corporate & Investor 978-657-0075 Relations general-info@cardiotech-inc.com 212-616-6161 info@vmwcom.com

SOURCE CardioTech International, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Another Medtronic Sprint Fidelis Lead Lawsuit is F...
S
Minority Women More Likely to Link Good Health to ...